切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2023, Vol. 12 ›› Issue (05) : 557 -561. doi: 10.3877/cma.j.issn.2095-3232.2023.05.016

所属专题: 临床研究

临床研究

ICG荧光染色在肝癌腹腔镜解剖性肝切除术中的应用
孟令展, 李虎, 俞鹏, 于燕宾, 曹李, 翟伟, 高远, 邵艳玲, 严锦, 朱震宇()   
  1. 100039 北京,解放军总医院第五医学中心肝病外科
  • 收稿日期:2023-06-11 出版日期:2023-10-10
  • 通信作者: 朱震宇
  • 基金资助:
    国家自然科学基金(92159305)

Application of ICG fluorescence staining in laparoscopic anatomical hepatectomy for primary liver cancer

Lingzhan Meng, Hu Li, Peng Yu, Yanbin Yu, Li Cao, Wei Zhai, Yuan Gao, Yanling Shao, Jin Yan, Zhenyu Zhu()   

  1. Department of Hepatic Surgery, the Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China
  • Received:2023-06-11 Published:2023-10-10
  • Corresponding author: Zhenyu Zhu
引用本文:

孟令展, 李虎, 俞鹏, 于燕宾, 曹李, 翟伟, 高远, 邵艳玲, 严锦, 朱震宇. ICG荧光染色在肝癌腹腔镜解剖性肝切除术中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 557-561.

Lingzhan Meng, Hu Li, Peng Yu, Yanbin Yu, Li Cao, Wei Zhai, Yuan Gao, Yanling Shao, Jin Yan, Zhenyu Zhu. Application of ICG fluorescence staining in laparoscopic anatomical hepatectomy for primary liver cancer[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(05): 557-561.

目的

探讨ICG荧光染色在原发性肝癌(肝癌)腹腔镜解剖性肝切除术中应用的可行性和安全性。

方法

回顾性分析2021年1月至2021年12月解放军总医院第五医学中心行腹腔镜解剖性肝切除术的52例肝癌患者临床资料。患者均签署知情同意书,符合医学伦理学规定。其中男40例,女12例;平均年龄(56±9)岁。中国肝癌分期(CNLC)Ⅰa期34例,Ⅰb期13例,Ⅱa期5例;肿瘤直径中位数3.1(1.1~13.2)cm。术前行三维可视化重建评估,术中超声引导下行ICG荧光染色。观察术中ICG染色情况、手术和术后情况、随访情况。

结果

所有患者均顺利完成手术。52例患者中45例染色成功,7例失败;其中采用反染法32例,染色失败2例,成功率94%;采用正染法20例,染色失败5例,成功率75%。手术方式包括腹腔镜右半肝切除术5例,左半肝切除术4例,右前叶切除术7例,右后叶切除术2例,肝中叶切除术2例,Ⅴ段切除术11例,Ⅵ段切除术1例,Ⅶ段切除术11例,Ⅷ段切除术9例。手术时间279(88~447)min,术中出血量200(50~500)ml。术后住院时间(9.1±3.5)d。术后出现并发症3例,其中胆漏1例,经引流后痊愈;胸腔积液1例,经胸腔穿刺引流后痊愈;肺部感染1例,予抗感染治疗后痊愈。术后未发生出血等并发症,无术后死亡。术后随访期间2例肝内复发。

结论

ICG荧光染色应用于腹腔镜解剖性肝切除术中安全可行。反染法成功率高,正染法尤其适用于后、上肝段等困难部位的解剖性肝段切除。

Objective

To evaluate the feasibility and safety of ICG fluorescence staining in laparoscopic anatomical hepatectomy for primary liver cancer (PLC).

Methods

Clinical data of 52 PLC patients who underwent laparoscopic anatomical hepatectomy in the Fifth Medical Center of Chinese PLA General Hospital from January to December 2021 were retrospectively analyzed. The informed consents of all patients were obtained and the local ethical committee approval was received. Among them, 40 patients were male and 12 female, aged (56±9) years on average. According to China Liver Cancer Staging (CNLC) System, 34 cases were classified as stage Ⅰa, 13 cases of stage Ⅰb and 5 cases of stage Ⅱa, respectively. The median tumor diameter was 3.1(1.1-13.2) cm. Three-dimensional visualization reconstruction and evaluation were performed before operation. Intraoperative ultrasound-guided ICG fluorescence staining was carried out. Intraoperative ICG staining, intraoperative and postoperative conditions, and postoperative follow-up were observed.

Results

All patients successfully completed the operation. Of 52 patients, ICG staining were performed successfully in 45 cases and failed in 7 cases. 32 patients were subject to reverse staining, and2 cases failed with a success rate of 94%. 20 cases received positive staining and 5 cases failed, with a success rate of 75%. Surgical methods included laparoscopic right hepatectomy in 5 cases, left liver resection in4 cases, right anterior lobectomy in 7 cases, right posterior lobectomy in 2 cases, middle lobe resection in2 cases, segment Ⅴ resection in 11 cases, segment Ⅵ resection in 1 case, segment Ⅶ resection in 11 cases and segment Ⅷ resection in 9 cases, respectively. The operation time was 279 (88-447) min, and intraoperative blood loss was 200 (50-500) ml. The length of postoperative hospital stay was (9.1±3.5) d. Postoperative complications occurred in 3 patients, including 1 case of bile leakage, which was treated after drainage, 1 case of pleural effusion, which was cured by thoracic puncture and drainage, and 1 case of pulmonary infection, which was healed after anti-infection treatment. No bleeding, other postoperative complications or death was observed. During postoperative follow-up, 2 cases developed intrahepatic recurrence.

Conclusions

It is safe and feasible to perform ICG fluorescence staining in laparoscopic anatomical hepatectomy. The success rate of reverse staining is high. Positive staining is especially suitable for anatomical hepatectomy of difficult segments, such as posterior and upper hepatic segments.

图1 荧光腹腔镜解剖性肝切除术前三维重建及模拟切割图注:a、b、c分别为右半肝切除、右前叶切除、右后叶切除三维重建
图2 荧光腹腔镜解剖性肝切除ICG染色方式注:a为肝Ⅶ段切除正染;b为右半肝切除反染;c为肝Ⅴ段亚段切除反染及肿瘤术前染色
[1]
Wakabayashi G, Cherqui D, Geller DA, et al. Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka[J]. Ann Surg, 2015, 261(4):619-629.
[2]
Abu Hilal M, Aldrighetti L, Dagher I, et al. The Southampton Consensus Guidelines for laparoscopic liver surgery: from indication to implementation[J]. Ann Surg, 2018, 268(1):11-18.
[3]
Aoki T, Yasuda D, Shimizu Y, et al. Image-guided liver mapping using fluorescence navigation system with indocyanine green for anatomical hepatic resection[J]. World J Surg, 2008, 32(8):1763-1767.
[4]
Xu Y, Chen M, Meng X, et al. Laparoscopic anatomical liver resection guided by real-time indocyanine green fluorescence imaging: experience and lessons learned from the initial series in a single center[J]. Surg Endosc, 2020, 34(10):4683-4691.
[5]
Liang X, Zheng J, Xu J, et al. Laparoscopic anatomical portal territory hepatectomy using Glissonean pedicle approach (Takasaki approach) with indocyanine green fluorescence negative staining: how I do it[J]. HPB, 2021, 23(9):1392-1399.
[6]
Aoki T, Koizumi T, Mansour DA, et al. Ultrasound-guided preoperative positive percutaneous indocyanine green fluorescence staining for laparoscopic anatomical liver resection[J]. J Am Coll Surg, 2020, 230(3):e7-12.
[7]
Otsuka Y, Matsumoto Y, Ito Y, et al. Intraoperative guidance using ICG fluorescence imaging system for safe and precise laparoscopic liver resection[J]. Minerva Surg, 2021, 76(3):211-219.
[8]
Xu H, Liu F, Hao X, et al. Laparoscopically anatomical versus non-anatomical liver resection for large hepatocellular carcinoma[J]. HPB, 2020, 22(1):136-143.
[9]
赵学勤, 朴纪颖, 张秉武, 等. 腹腔镜解剖性肝切除术与非解剖性肝切除术的前瞻性对比研究[J/CD]. 中华普外科手术学杂志(电子版), 2020, 14(6):581-584.
[10]
Haruki K, Furukawa K, Fujiwara Y, et al. Effectiveness of anatomical resection for small hepatocellular carcinoma: a propensity score-matched analysis of a multi-institutional database[J]. J Gastrointest Surg, 2021, 25(11):2835-2841.
[11]
王晓耘, 马增辉, 史佩东. 解剖性肝段切除术关键技术和争议[J/OL]. 中华肝脏外科手术学电子杂志, 2020, 9(4):317-320.
[12]
蔡柳新, 姜文斌. 腹腔镜Glisson蒂横断式肝切除[J/OL]. 中华肝脏外科手术学电子杂志, 2021, 10(4):357-359.
[13]
王晓颖, 高强, 朱晓东, 等. 腹腔镜超声联合三维可视化技术引导门静脉穿刺吲哚菁绿荧光染色在精准解剖性肝段切除术中的应用[J]. 中华消化外科杂志, 2018, 17(5):452-458.
[14]
Ito D, Ishizawa T, Hasegawa K. Laparoscopic positive staining of hepatic segments using indocyanine green-fluorescence imaging[J].J Hepatobiliary Pancreat Sci, 2020, 27(7):441-443.
[15]
Felli E, Ishizawa T, Cherkaoui Z, et al. Laparoscopic anatomical liver resection for malignancies using positive or negative staining technique with intraoperative indocyanine green-fluorescence imaging[J]. HPB, 2021, 23(11):1647-1655.
[16]
Li WF, Al-Taher M, Yu CY, et al. Super-selective intra-arterial indocyanine green administration for near-infrared fluorescence-based positive staining of hepatic segmentation: a feasibility study[J]. Surg Innov, 2021, 28(6):669-678.
[17]
Ueno M, Hayami S, Sonomura T, et al. Concomitant use of indocyanine green fluorescence imaging and interventional radiology for detection of liver segments during laparoscopic anatomical liver resection: pilot feasibility study[J]. Surg Laparosc Endosc Percutan Tech, 2019, 29(4):242-246.
[18]
Monden K, Sadamori H, Hioki M, et al. Intrahepatic Glissonean approach for laparoscopic bisegmentectomy 7 and 8 with root-side hepatic vein exposure[J]. Ann Surg Oncol, 2022, 29(2):970-971.
[19]
中国研究型医院学会微创外科学专业委员会,《腹腔镜外科杂志》编辑部. 吲哚菁绿荧光染色在腹腔镜肝切除术中应用的专家共识[J]. 腹腔镜外科杂志, 2019, 24(5):388-394.
[20]
Wakabayashi T, Cacciaguerra AB, Abe Y, et al. Indocyanine green fluorescence navigation in liver surgery: a systematic review on dose and timing of administration[J]. Ann Surg, 2022, 275(6):1025-1034.
[1] 燕速, 霍博文. 腹腔镜食管胃结合部腺癌根治性切除术[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 13-13.
[2] 母德安, 李凯, 张志远, 张伟. 超微创器械辅助单孔腹腔镜下脾部分切除术[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 14-14.
[3] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[4] 李子禹, 卢信星, 李双喜, 陕飞. 食管胃结合部腺癌腹腔镜手术重建方式的选择[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 5-8.
[5] 李乐平, 张荣华, 商亮. 腹腔镜食管胃结合部腺癌根治淋巴结清扫策略[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 9-12.
[6] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[7] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[8] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[9] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[10] 王庆亮, 党兮, 师凯, 刘波. 腹腔镜联合胆道子镜经胆囊管胆总管探查取石术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 313-313.
[11] 杨建辉, 段文斌, 马忠志, 卿宇豪. 腹腔镜下脾部分切除术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 314-314.
[12] 叶劲松, 刘驳强, 柳胜君, 吴浩然. 腹腔镜肝Ⅶ+Ⅷ段背侧段切除[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 315-315.
[13] 郭兵, 王万里, 何凯, 黄汉生. 腹腔镜下肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 143-143.
[14] 李凯, 陈淋, 苏怀东, 向涵, 张伟. 超微创器械在改良单孔腹腔镜巨大肝囊肿开窗引流及胆囊切除中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 144-144.
[15] 魏丽霞, 张安澜, 周宝勇, 李明. 腹腔镜下Ⅲb型肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 145-145.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?